Top Markets
Coin of the day
IR Biosciences Holdings Inc. IR Biosciences Holdings Inc.

IR Biosciences Holdings Inc.

IRBS
株式のランク #40520
IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm.... IR BioSciences Holdings, Inc. is a U.S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation. The company is also actively developing Homspera and its derivatives, Radilex and Viprovex. These compounds are designed to stimulate human stem cells, enhance immune system responses, offer anti-infective properties, serve as vaccine adjuvants, and promote wound healing. Founded in 1999, IR BioSciences Holdings, Inc. maintains its headquarters in Scottsdale, Arizona.
株価
$0.00006
最終同期: 2025-07-15
時価総額
$128.12K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 IR Biosciences Holdings Inc. (IRBS)

カテゴリー

IR Biosciences Holdings Inc.(IRBS)の配当利回りの履歴
IR Biosciences Holdings Inc.(銘柄コード: IRBS)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
IR Biosciences Holdings Inc.(IRBS)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)